Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy

NCT01921998 is registered in ClinicalTrials.gov with The Christie NHS Foundation Trust as lead sponsor.

NCT NCT01921998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01921998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
Lead sponsor
The Christie NHS Foundation Trust
Phase
Observational
Overall status
Suspended
Start date
October 31, 2013
Completion date
Not reported
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, sarcoma